Autopsy report · NCT03862131

PROactive Evaluation of Function to Avoid CardioToxicity

“Insufficient funding/staff”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 years 3 months before it stopped.
• 49 participants enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Washington University School of Medicine

Sponsor type

University, hospital or other

Conditions

Cardiotoxicity; Breast Cancer; Lymphoma; Sarcoma; Leukemia; Myeloma

Interventions

MyoStrain®

Participants

49

Sites

1

Countries

United States

Trials that died the same way

• Hatha Yoga in Breast Cancer Survivors
  “Insufficient staff and funding” (98% match in meaning)
• Understanding Effects of Cannabis Use and Abstinence on Neural Glutamate Homeostasis
  “Insufficient funding” (90% match in meaning)
• Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery
  “insufficient funding and recruitment” (80% match in meaning)
• Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
  “Insufficient accrual and no funding” (80% match in meaning)
• EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.
  “Inadequate funding” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.